Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


The microbiome influence

Science 359, 91–97 (2018).

Science 359, 97–103 (2018).

Science 359, 104–108 (2018).

In the form of immunotherapy known as immune checkpoint inhibition, therapies are administered that release the breaks (i.e., checkpoints) on the immune system to activate it against cancer. This approach has had a major impact on cancer treatment, but not all individuals treated with this therapy respond.

Researchers from the United States and France found that the composition of the gut microbiome can influence an individual’s response to immune checkpoint inhibition. The researchers in France found that antibiotic treatment inhibits the effectiveness of this kind of immunotherapy treatment, and the US scientists found that patients with melanoma who did not respond to immune checkpoint inhibition drugs had an imbalance of gut flora, hampering their immune response against cancer.

In the future, the composition of the gut microbiome could be manipulated to enhance the effectiveness of immune checkpoint inhibition or used as a biomarker to gauge potential response.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Hannah Stower.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Stower, H. The microbiome influence. Nat Med 24, 1782 (2018).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing